Matthew Jalink

Publication Activity (10 Years)

Years Active: 2022-2022
Publications (10 Years): 5

Top Topics

Palliative Care

Cross Sectional

Childhood Cancer

Top Venues

JCO global oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Manju Sengar, Adam M Fundytus, Wilma M Hopman, Conjeevaram S Pramesh, Venkatraman Radhakrishnan, Prasanth Ganesan, Aju Mathew, Dorothy Chilambe Lombe, Matthew Jalink, Bishal Gyawali, Dario Trapani, Felipe Santa Rosa Roitberg, Elisabeth G E De Vries, Lorenzo Moja, Gerald W Prager, Richard Sullivan, Christopher M Booth
Cancer Medicines: What Is Essential and Affordable in India? JCO global oncology 8 (2022)
Sanjeeva Gunasekera, Sanjeewa Seneviratne, Matthew Jalink, Nuradh Joseph, Yasantha Ariyarathna, Christopher M Booth, Don Thiwanka Wijeratne
Clinical Oncology Workload in Sri Lanka: Infrastructure, Supports, and Delivery of Clinical Care. JCO global oncology 7 (2022)
Avram E Denburg, Adam M Fundytus, Muhammad Saghir Khan, Scott C Howard, Federico Antillon-Klussmann, Manju Sengar, Dorothy Chilambe Lombe, Wilma M Hopman, Matthew Jalink, Bishal Gyawali, Dario Trapani, Felipe Santa Rosa Roitberg, Elisabeth G E De Vries, Lorenzo Moja, Gerald W Prager, Richard Sullivan, Christopher M Booth
Defining Essential Childhood Cancer Medicines to Inform Prioritization and Access: Results From an International, Cross-Sectional Survey. JCO global oncology 8 (2022)
Bishal Gyawali, Niresh Thapa, Colleen Savage, Laura Mae Carson, Matthew Jalink, Mangal Rawal, Scott Berry, Bishesh S Poudyal
Training General Practitioners in Oncology: A Needs Assessment Survey From Nepal. JCO global oncology 8 (2022)
Don Thiwanka Wijeratne, Sanjeeva Gunasekera, Christopher M Booth, Scott Berry, Matthew Jalink, Laura Mae Carson, Bishal Gyawali, Hasitha Promod, Umesh Jayarajah, Sanjeewa Anuruddha Seneviratne
Colorectal Cancer Treatment Characteristics and Concordance With Guidelines in Sri Lanka: Results From a Hospital-Based Cancer Registry. JCO global oncology 8 (2022)